Salvatore Lopez
0000-0001-7705-3715
Istituto Nazionale dei Tumori
2 papers found
Refreshing results…
Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan
PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib
Missing publications? Search for publications with a matching author name.